PHASEBIO PHARMACEUTICALS INC - COM (PHASQ)

CUSIP: 717224109

Q1 2021 13F Holders as of 31 Mar 2021

Type / Class
Equity / COM
Total 13F shares
31,841,834
Share change
+15,915,060
Total reported value
$110,151,220
Put/Call ratio
112%
Price per share
$3.46
Number of holders
59
Value change
+$55,091,388
Number of buys
32
Number of sells
21

Quarterly Holders Quick Answers

What is CUSIP 717224109?
CUSIP 717224109 identifies PHASQ - PHASEBIO PHARMACEUTICALS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of PHASEBIO PHARMACEUTICALS INC - COM (PHASQ) as of Q1 2021

As of 31 Mar 2021, PHASEBIO PHARMACEUTICALS INC - COM (PHASQ) was held by 59 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 31,841,834 shares. The largest 10 holders included NEA Management Company, LLC, WELLINGTON MANAGEMENT GROUP LLP, Avidity Partners Management LP, RA CAPITAL MANAGEMENT, L.P., Endurant Capital Management LP, Johnson & Johnson Innovation - JJDC, Inc., VANGUARD GROUP INC, Rock Springs Capital Management LP, BlackRock Inc., and Altium Capital Management LP. This page lists 59 institutional shareholders reporting positions in this security for the Q1 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.